David Kay

This inventor holds 53 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 18 EPO patents, primarily in Protein Kinase Inhibitors (CPC class C07D). Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Kay. Retrieved from https://idiyas.com/inventor/david-kay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 (Patent Applications = 11)

% Patents Active = 35.8

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 18 (Patent Applications = 15)

Average Co-Inventor Count = 6.4

ph-index = 22

Forward Citations = 1,430(Granted Patents)

Forward Citations (Not Self Cited) = 1,272(Dec 10, 2025)

Inventors with similar research interests:

Location History:

4 Church Path, GB (2003)
Purton Wiltshire, GB (2003)
Milton Park, GB (2012)
Abingdon, GB (2010 - 2013)
Wiltshire, GB (2004 - 2017)
Purton, GB (2003 - 2022)

Company Filing History:

53 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

ATR Kinase

Protein Kinase

Pyrazines

Pyrimidines

Aminopyrazines

Thiophene-Carboxamides

Dihydrodiazepines

Fused Cyclic Systems

Pteridines

Substituted Compounds

Inhibitors

Compositions

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187731 - Compounds useful as inhibitors of ATR kinase (2025-01-07),

2. 11370798 - Compounds useful as inhibitors of ATR kinase (2022-06-28),

3. 11117900 - Compounds useful as inhibitors of ATR kinase (2021-09-14),

4. 10961232 - Substituted pyrazines as ATR kinase inhibitors (2021-03-30),

5. 10787452 - Compounds useful as inhibitors of ATR kinase (2020-09-29),

6. 10479784 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2019-11-19),

7. 10392391 - Compounds useful as inhibitors of ATR kinase (2019-08-27),

8. 9718827 - Compounds useful as inhibitors of ATR kinase (2017-08-01),

9. 9701674 - Substituted pyrazines as ATR kinase inhibitors (2017-07-11),

10. 9663519 - Compounds useful as inhibitors of ATR kinase (2017-05-30),

11. 9650381 - Compounds useful as inhibitors of ATR kinase (2017-05-16),

12. 9630956 - Compounds useful as inhibitors of ATR kinase (2017-04-25),

13. 9365557 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2016-06-14),

14. 9340546 - Compounds useful as inhibitors of ATR kinase (2016-05-17),

15. 8969360 - Compounds useful as inhibitors of ATR kinase (2015-03-03),

Title: The Inventor David Kay: Pioneering Innovations in Purton, GB

Introduction: David Kay is a renowned inventor based in Purton, GB, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: David Kay holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of expertise and interests.

Career Highlights: Throughout his illustrious career, David Kay has been recognized for his ability to transform ideas into tangible inventions that have had a significant impact on society. His commitment to pushing the boundaries of innovation has led to the development of cutting-edge solutions that address complex challenges.

Collaborations: David Kay has collaborated with leading companies, research institutions, and universities to further his inventions and bring them to market. His partnerships have been instrumental in bridging the gap between groundbreaking ideas and real-world applications.

Conclusion: David Kay's passion for innovation, coupled with his relentless drive to create a positive change, solidifies his position as a trailblazing inventor in Purton, GB, and beyond.

Profile summary based on public USPTO records.